OlyLife
A device whose headline claim is off by two orders of magnitude, sold by a company that will not name its founder.
Anonymous ownership, an unpublished income record, and a penetration claim physics does not support.
Can you actually make money with OlyLife?
No, and the reason is a first-order physical fact rather than an opinion about the compensation plan. The marketing advertises a penetration depth of four to five centimetres beneath the skin. The peer-reviewed literature on terahertz radiation puts it at a couple of hundred micrometres, because water absorbs it very strongly. That is a gap of roughly two hundred times on how far energy travels through tissue, and it is not the kind of question reasonable people disagree about.
The terms are genuinely the best dimension here and it would be unfair to bury them. No autoship. No monthly minimum. Nothing to maintain month to month. A thirty-day buyback of unopened product, and a ten-working-day cooling-off period that applies only to members in Malaysia, Indonesia, Thailand and Singapore. Disputes go to mandatory, binding arbitration. The written policies also prohibit medical claims, and that is real credit even though the field marketing runs the other way.
You also cannot get the plan from the company. OlyLife publishes no compensation plan; its policies incorporate one by reference without attaching it, so every copy in circulation is distributor-hosted or third-party. Those copies agree on the main packages ($1,000, $2,000 and $6,000; one adds $100 and $500 starter tiers) but not on what the money buys: the plan deck calls each package a product purchase, while a third-party analysis says a $1,000 package carries a $375 product voucher, which would leave 62.5% of the payment (our arithmetic) as something other than product. Contract manufacturers list same-description devices at $460 to $499, against the company’s own $1,000 list price for the Tera-P90.
The company does not name its founder, owners or officers. The About page mentions the founder once without a name, and the CEO that promoters cite has no verifiable record outside company marketing. The website and FDA records do name the entities: Olylife Limited in Hong Kong and OlyLife International Sdn. Bhd. in Malaysia. There is no income disclosure. The policies say only that no income is guaranteed, while the plan deck advertises $1.2 billion in commissions paid and 200+ millionaires with nothing behind either figure.
package purchase; the plan deck shows $1,000, $2,000 and $6,000, and a third-party analysis adds $100 and $500 starter tiers
- A named founder and named owners. The operating entities are named (Olylife Limited in Hong Kong, OlyLife International Sdn. Bhd. in Malaysia), but no founder, shareholder or officer is, and the About page calls its founder only "the founder".
- A compensation plan published by the company itself. OlyLife’s policies incorporate a plan they do not attach, so a prospect relies on distributor-hosted and third-party copies, which disagree on whether a package buys its full price in product or a voucher worth 37.5% of it.
- A penetration claim that matches the physics, or removal of the claim. Four to five centimetres against a measured couple of hundred micrometres is the finding this entire file turns on.
- A response to the report in the US regulator's device-experience database describing burns, wounds and a hospitalisation from the flagship device - consistent with a product manual that warns about overheating three separate times.
That call is computed, not chosen - the rule reads three of the nine published dimension scores and is printed on the methodology page. It describes this company's plan and the figures it publishes about the people already in it. It is not a prediction about you, and nothing on this site is advice.
Legal status
NO ADJUDICATED ILLEGALITY in the US - one foreign regulator has recorded the device as unregistered, and the US device listing is exemption-based rather than cleared.
Confidence: Medium
Primary sources fetched directly where possible. Everything we could not verify is listed at the bottom of this page by name.
Follow the money
A network-marketing company selling "terahertz" therapy devices, led by the Tera-P90, a foot-plate unit the company lists at $1,000, through package-based distributor entry at $1,000, $2,000 or $6,000 (a third-party analysis also lists $100 and $500 starter tiers).
The product claim is where this file is decided, so take it directly. The marketing advertises a penetration depth of four to five centimetres beneath the skin. The peer-reviewed literature on terahertz radiation is unambiguous in the other direction: water absorbs it very strongly, and it penetrates human skin only a couple of hundred micrometres. That is a discrepancy of roughly two hundred times on a first-order physical property. This is not a dispute about clinical efficacy, where reasonable people disagree - it is a claim about how far energy travels through tissue, and the physics is settled.
The regulatory position needs stating carefully because it is widely misreported in both directions. The company holds a US establishment registration and lists a device under a product code that is Class I and exempt from premarket notification. That is not clearance, and it is not approval. No terahertz device has ever received a 510(k) - a search of the clearance database returns nothing for the category. And the exemption itself is conditional: it covers a narrow intended use, and it is void where a device is marketed for a different intended use or works on a different fundamental technology, which the marketing asserts it does.
Two further things belong in any honest summary. A report in the US regulator's public device-experience database describes multiple patients presenting with burns, wounds and injuries from the flagship device, including a hospitalisation, filed by a nurse - and it is consistent with the product manual, which warns about overheating three separate times. And one national regulator, in Thailand, has recorded the device on an illegal-products list on the basis that no medical device registration was found. No US or European authority has acted, which is worth saying plainly, but "not found" is not the same as "cleared."
What an entry package actually buys
Product value against the remainder of the payment
| Product | Price | Pays |
|---|---|---|
| Tera-P90 (flagship foot-plate device) The core device. Contract manufacturers list same-description units at $460 to $499. |
$1,000 ($1,500 for the P90+ bundle) one-time |
package-dependent |
| Leader package (P3) The plan deck calls it a product purchase; a third-party analysis says it carries a $375 product voucher and lists $100 and $500 starter tiers below it. |
$1,000 one-time |
varies |
| Pioneer package (P5) The same question at a larger number: a product purchase per the deck, or a $2,250 product voucher per the third-party analysis. |
$6,000 one-time |
varies |
| Autoship Genuinely absent. There is no monthly minimum and nothing to maintain, which is a real point in the company's favor. |
None — |
— |
| Cooling-off and buyback Ten working days of cooling-off, but only for members in Malaysia, Indonesia, Thailand and Singapore; a thirty-day buyback of unopened, resaleable product, with transfer costs borne by the distributor. |
10 days / 30 days — |
— |
Who runs it, and what they ran before
The About page mentions "the founder" once and never gives a name. For a company selling a health device at four figures, an unnamed principal is a material disclosure failure rather than a stylistic choice.
Named as CEO by OlyLife promoters, per a third-party review; no company document in the sources names her, and the only person the company website attaches to the brand is a sports-celebrity ambassador. No verifiable professional record was located outside the company's own marketing.
Registered address
Kuala Lumpur, Malaysia (FDA registrant); website operated by Olylife Limited, Hong Kong; US agent in Lewes, Delaware
The corporate About page mentions "the founder" once and never names anyone. The site footer says olylife.com is owned and operated by Olylife Limited (Hong Kong), and the contact page lists OlyLife International Sdn. Bhd. offices in Kuala Lumpur and Johor Bahru plus entities in Singapore, Thailand and Indonesia. The FDA registration names OlyLife International Sdn. Bhd., Kuala Lumpur, with a US agent in Lewes, Delaware. No owner, director or responsible officer is named.
The veteran's checklist
Eight questions that decide whether this is a business or a transfer mechanism. Same eight, every review.
| Question | Answer |
|---|---|
| Who legally owns it? |
RED
Owners not disclosed. The About page refers only to "the founder"; the named entities are Olylife Limited (Hong Kong) and OlyLife International Sdn. Bhd. (Malaysia).
|
| Where is it incorporated? |
RED
Malaysia (OlyLife International Sdn. Bhd., 1460145-W) and Hong Kong (Olylife Limited, the website operator); the FDA lists a US agent in Lewes, Delaware.
|
| Regulatory action, ever? |
CONCERN
One foreign listing recording the device as unregistered (Thailand, Feb 2025). No US, Canadian, UK, Australian or EU action found.
|
| Published income disclosure? |
RED
None. Only a disclaimer disclaiming figures never published.
|
| What does it take to break even? |
RED
Cannot be calculated. The company publishes no compensation plan, and no income disclosure exists.
|
| Do I own the list? |
RED
No. And the company owns a customer relationship you cannot attribute to a named entity.
|
| Is the product claim supported? |
RED
No. The advertised 4–5 cm penetration is contradicted by peer-reviewed physics by roughly two hundred times.
|
| Merchant play or miner play? |
RED
Miner. By one third-party reading, roughly 63% of an entry payment is not product, and comparable hardware is listed at about half the price elsewhere.
|
What has to be true for you to get paid
| To cover | You need |
|---|---|
| Recover a $1,000 entry package | 1–2 package sales plan-dependent; the company publishes no plan |
| Recover a $6,000 package | Substantially more and the payout terms are not published by the company |
| Know the commission rates | No company-published plan exists only distributor and third-party copies |
| Know what anyone earns | No disclosure exists only a disclaimer |
Read this twice
Every line here fails on the same point: you cannot do this arithmetic, because the company has not published the inputs. The company publishes no compensation plan of its own, no income disclosure exists in any form, and the only revenue figures in the sources are the plan deck’s own unsupported claims. A breakeven calculation requires numbers, and the numbers are not there.
Run your own numbers
Drag the sliders. Nothing here is stored or sent.
Direct sales bonus on a $1,000 Leader package: 10% of 750 BV, per a third-party plan analysis, plus a product voucher that is not cash. Binary and matching income is not modeled. Treat every figure as indicative only: the company publishes no compensation plan, and no income disclosure exists. Your own subscription cost of $0/mo is included.
What it costs to replace this yourself
What the same hardware costs from the people who make it, and what the underlying modalities cost separately.
| What they sell you | What you'd use instead | Your cost |
|---|---|---|
| Tera-P90 - $1,000 list | Same-description device from a contract manufacturer | $460 to $499 |
| PEMF function | A standalone consumer PEMF mat or unit | $200–600 |
| Heat therapy function | A conventional heating pad | $25–60 |
| Light therapy function | A red-light therapy panel | $100–400 |
| The therapeutic claim | A physiotherapist consultation | $60–150 once |
| Total as sold $1,000 to $6,000 to enter (deck tiers) |
Total, built yourself Under $500 for comparable hardware |
Price-to-value
The hardware is listed at about half the company’s list price by the kind of factory that makes it. What the premium buys is the distributorship, not the device - which is the clearest possible statement of where the value in this offer actually sits.
Three operators, five horizons
Probability of cumulative net profit
Hover any point for median, top decile and bottom quartile.
Buyer / user
Buys the device for personal use only
| Horizon | P(profit) | Median |
|---|---|---|
| 3 mo | 4% | −$1,400 |
| 6 mo | 6% | −$1,400 |
| 1 yr | 6% | −$1,400 |
| 3 yr | 6% | −$1,400 |
| 5 yr | 6% | −$1,400 |
Distributor
Buys a package and sells actively
| Horizon | P(profit) | Median |
|---|---|---|
| 3 mo | 14% | −$1,800 |
| 6 mo | 20% | −$2,400 |
| 1 yr | 22% | −$2,800 |
| 3 yr | 14% | −$5,000 |
| 5 yr | 10% | −$7,000 |
Established operator
Large audience, sells high packages
| Horizon | P(profit) | Median |
|---|---|---|
| 3 mo | 44% | +$2,000 |
| 6 mo | 40% | +$3,400 |
| 1 yr | 28% | +$1,000 |
| 3 yr | 12% | −$12,000 |
| 5 yr | 8% | −$20,000 |
Methodology note. MODELED, with the lowest confidence of any file we have published, because there is almost nothing to model from - no company-published compensation plan, no income disclosure, no verifiable revenue and no named owner or officer. The buyer row is flat because a personal-use purchase is simply a cost. The declining curves elsewhere price in the regulatory and reputational exposure of marketing a therapeutic device whose central claim the literature contradicts.
Where you are actually allowed to promote this
Platform policy reads, not verifications. Check every one before you spend a dollar - enforcement changes faster than the written policy does.
Red flags and green flags
Red flags
121The penetration claim is contradicted by physics by roughly two hundred times
2The founder is not named anywhere
3A device-injury report describing burns and hospitalisation
4No terahertz device has ever received FDA clearance
5A foreign regulator has listed the device as unregistered
6No income disclosure exists
7The company publishes no compensation plan
8By one third-party reading, roughly 63% of an entry payment is not product
9The hardware is listed at about half the price
10The revenue figures in circulation are unverifiable
11The marketing and the manual contradict each other
12The entire field proposition is therapeutic
Green flags
71No autoship and no monthly minimum
2A thirty-day buyback, and cooling-off in four countries
3The written policies prohibit medical claims
4A real product does ship
5No adjudicated illegality anywhere
6No securities component
7The product manual is responsible
We would like to be wrong about this
Upward
- Disclosure of a named founder, owners and officers, and a compensation plan published by the company itself.
- Withdrawal or substantiation of the penetration-depth claim, and publication of an income disclosure.
- A 510(k) clearance for the device, or any positive determination by a competent health authority.
Downward
- Any FDA warning letter, import alert or state action, or a further national regulator listing.
- Additional device-injury reports, or evidence that reported injuries were not addressed.
- Evidence that the buyback and cooling-off terms are not honored in practice.
Grade is D-. Not because anyone has been convicted of anything - nobody has - but because almost nothing here can be verified, and the one central claim that can be checked does not hold.
Set the compensation plan aside for a moment and look only at what a buyer is told. The device penetrates four to five centimetres. The literature says a couple of hundred micrometres. That is a two-hundred-fold discrepancy on a physical property that is not in scientific dispute, and it is the claim the entire therapeutic proposition rests on. Everything downstream of it - the packages, the ranks, the income story - is built on that one sentence.
Then look at what you cannot check. The founder is not named. No owner or officer is named. The company publishes no compensation plan of its own. No income disclosure exists. The only revenue figures are the plan deck’s own unsupported claims. And contract manufacturers list comparable hardware at about half the company’s list price - which tells you plainly that what the premium buys is the distributorship rather than the device.
For anyone considering promoting this rather than buying it, the exposure is unusually personal. Marketing an uncleared device for treating disease is not a gray area, and the liability attaches to whoever made the claim. The company's own policies prohibit medical claims, so a distributor making them is in breach of their own agreement as well as of the law - and the company will be pointing at that policy, not at you.
Buy the hardware, not the position
If you want the device, contract manufacturers list same-description units at $460 to $499. The package premium is buying a distributorship.
Never make a therapeutic claim
It is prohibited by the company's own policies and by law, and the liability lands on whoever published it. There is no version of this where the claim is safe to make.
Ask for the plan in writing before paying
The company’s policies incorporate a compensation plan they do not attach, and the copies in circulation disagree on whether a package buys product or a voucher. If the company cannot produce one authoritative document, that answers the question.
Sell wellness services you can stand behind
The audience for credible recovery and wellness services is large and growing. Building it around equipment you can describe accurately - and an entity you can name - is a better business and carries none of this exposure.
Nine dimensions, weighted
Dimension profile
Further from center is better. Hover any point.
Hard caps that bind here
The lowest binding cap wins, regardless of the weighted arithmetic.
What we read
Every source below links to the document itself. Tier 1 is a primary record - the company’s own plan, policy or disclosure, a court filing, a regulator’s decision or an SEC filing. Tier 2 is a self-regulatory or secondary regulator record, tier 3 reporting or academic work, tier 4 an open-market price comparison. Where a document can be moved or withdrawn, an archived copy is linked beside it. If a link is dead when you try it, that is a correction we want.
- FDA MAUDE device-event report MW5186559, received 9 April 2026: OLYLIFE TERA P90 (manufacturer OlyLife International Sdn. Bhd.), event type Injury, reporter a nurse, patient outcome hospitalization, patient problems superficial burn and unspecified tissue injury; narrative "Multiple patients seen with burns, wounds and injuries utilizing OlyLife Tera P90."
Retrieved through the openFDA device-event API on 6 Oct 2026. A MAUDE report is a submitted account, not an FDA finding that the device caused the injury.
- olylife.com - corporate site and About text ("OlyLife was founded in 2022…"; site operated by Olylife Limited)
olylife.com - product pages, About page, policies and procedures, product manual
Not established by this document: OlyLife does not host its product manuals as downloadable files on olylife.com; both manuals are cited from manuals.plus, which reproduces the company documents in full.
- OlyLife Tera-P90 product page - 1 MHz bioelectromagnetic energy, "focused band of 3-3000μm", claimed penetration "4-5 cm under the skin", listed at $1,000
- OlyLife THz Tera-P90+ product page - main device plus Frost Age Beauty Device and Revitaluxe Massager, 20-level intensity control, listed at $1,500
- OlyLife Policies and Procedures (company PDF) - Distributor Agreement, bonus qualification, "No Earning Guarantee", seven-day commission payment, bonus clawback on refunds
- OLYLIFE INTERNATIONAL SDN. BHD. (1460145-W) Policy and Procedures, version 5.0 (Malaysia edition, PDF)
- OlyLife Policies and Procedures - earlier posted edition with Sections 7–9 (payment of bonuses and overrides, sales and pricing) (PDF)
- OlyLife THz Tera-P90 PEMF Therapy Machine instruction manual - operating panel, 30-minute default cycle, warning that concurrent electrotherapy "may cause burns" (company manual, third-party mirror)
- OlyLife Tera-P90 Terahertz and PEMF Frequency Device owner's manual - the "pulsed magnetoelectric" and demagnetisation rationale, and the claimed efficacy list (company manual, third-party mirror)
- "Terahertz radiation and the skin: a review", Journal of Biomedical Optics - penetration depth into skin of 0.1 to 0.3 mm on average
Peer-reviewed review of terahertz interaction with biological tissue establishing sub-millimetre penetration in skin
- "THz Sensing of Human Skin: A Review of Skin Modeling Approaches", Sensors 21(11):3624 - short penetration depth caused by water attenuation; typically under 100 μm for modeling purposes
- "Past, present and future of in vivo THz skin sensing", Journal of Physics: Photonics - penetration into skin limited to approximately 0.1–0.5 mm, effectively the epidermis and immediately subjacent layers
- FDA Establishment Registration & Device Listing record - OLYLIFE INTERNATIONAL SDN BHD, Kuala Lumpur; registration/FEI 3027436335; owner/operator 10088116; US agent in Lewes, Delaware
US FDA establishment registration and device listing under a Class I exemption; 21 CFR 890.5660 and 21 CFR 890.9 on exemption scope
Not established by this document: eCFR blocks programmatic access and returned a CAPTCHA interstitial for the 890.9 request, so that section is marked "listed" rather than "verified"; 890.5660 was retrieved and confirmed as "Therapeutic massager".
- FDA device listing for registration 3027436335 - device type "massager, therapeutic, electric"; proprietary names OLYLIFE Shaken Massager SK-M3 and OLYLIFE THz Tera-P90+, Model P90+ (no premarket submission number)
- 21 CFR 890.5660 - Therapeutic massager (eCFR current text)
- 21 CFR 890.9 - Limitations of exemptions from section 510(k) of the Federal Food, Drug, and Cosmetic Act (eCFR current text)
- FDA Establishment Registration & Device Listing database (search entry point)
FDA 510(k) clearance database - no clearances located for any terahertz therapy device
Not established by this document: A null result in the 510(k) premarket-notification database has no stable, citable URL - the database returns results only against a POSTed query, and a "no records found" page cannot be linked. The affirmative, linkable evidence for the same proposition is the device-listing record cited at index 2: OlyLife's own FDA listing carries a Class I therapeutic-massager product code and no premarket submission number, which is what a listing without a 510(k) clearance looks like.
- FDA Product Classification Database (search entry point for the therapeutic-massager product code and its exemption status)
- FDA MAUDE database - text search interface for medical device adverse event reports
FDA MAUDE device-experience report describing burns, wounds and hospitalisation associated with the flagship device
Not established by this document: The individual MDR describing burns, wounds and hospitalisation could not be linked. MAUDE detail pages are addressed by an internal mdrfoi__id that is only obtainable by running a search, and every attempt to query accessdata.fda.gov returned FDA's rate-limiting "excessive requests" interstitial rather than results. Until the specific report number is captured, this claim rests on an unlinked database lookup and should be treated as unverified in the published grade.
- FDA - "About Manufacturer and User Facility Device Experience (MAUDE)", explaining report fields including patient outcome codes such as Hospitalization
- Thai FDA illegal-products alert, 14 February 2025 - "อย.เตือนภัยผลิตภัณฑ์ OlyLife THz Tera-P90": on checking, no medical-device registration was found for the product
Thai FDA illegal-products record, 14 February 2025 - no medical device registration found; Thailand Consumer Council coverage
- Thailand Consumer Council alert - "อย. เตือนผลิตภัณฑ์ OlyLife THz Tera-P90 โฆษณาสรรพคุณเกินจริง" (overstated efficacy claims; no medical-device registration)
- Anti-Fake News Center Thailand, 22 January 2025 - "ผลิตภัณฑ์ OlyLife THz Tera-P90 รักษาอาการบาดเจ็บ": claim assessed as not yet registered as a medical device with the Thai FDA and efficacy claims not officially evaluated
- Made-in-China listing - Guangzhou Danye Optical Co., Ltd., model DY-FM Plus "Thz Tera P90 Terahertz Device Pemf Therapy Foot Massage": PEMF + THz + red/blue LED, 1 MHz electromagnetic energy, timer 1–60 min, heat levels L1–L20, OEM/ODM available, MOQ 1 unit
Contract-manufacturer listings for same-specification PEMF and terahertz devices
Not established by this document: These are open-market supplier listings for devices of the same description and specification sold OEM/ODM at wholesale; they are not evidence that any named factory manufactures for OlyLife, and no supply relationship is asserted.
- Made-in-China listing - Shenzhen Guangyang Zhongkang Technology Co., Ltd. (Suyzeko), "OEM&ODM Factory New Upgrade Thz Tera P90 P95 P100 Foot Massage PEMF and RF Terahertz Therapy Device", model GY-SQT-02
- Alibaba listing - Guangzhou Mejinlay Technology Co., Ltd., "Olylife Tera P90 TeraHertz P100 Foot Massage Device", model MJL-FM06, PEMF + THz, OEM/ODM
- OlyLife compensation-plan deck ("OlyLife Highlights", Hawaii theme) - package tiers of $1,000, $2,000 and $6,000; Infinity Tier Bonus of $375 per matched level on the $1,000 tier; Team Bonus 11%–13%; Direct Sales Bonus 10% of product PV; Global Pool at 14 left and 14 right (PDF, distributor-hosted)
Two circulating versions of the compensation plan giving conflicting package pricing
Not established by this document: OlyLife publishes no compensation plan on olylife.com - its own Policies and Procedures incorporate "the OlyLife Compensation plan" by reference without linking or attaching it - so all four citations are distributor-hosted or third-party copies. That absence is itself the reason two mutually inconsistent versions circulate, and neither can be shown to be the authoritative one.
- "Olylife Marketing and Compensation Plan" - the Malaysian-ringgit version, four membership tiers from RM180 to RM2,520 with nine bonus types (conflicting package structure)
- OlyEmpire compensation-plan explainer - six income streams and $1K / $2K / $6K package comparison with binary rates of 11%/12%/13% and daily caps to $7,000
- BehindMLM - "OlyLife Review: Alibaba junk pyramid scheme": a five-tier plan, P1 Starter $100 to P5 Pioneer $6,000 with 70–4,500 BV, seven ranks, and daily binary caps of ~$103 to ~$7,078 - materially different package pricing from the three-tier deck above
What we could not get
- The operating legal entity, its jurisdiction, and the identity of the founder
- Reported revenue and growth - traces to a single aggregator with no methodology and no filed accounts
- Which of the two circulating compensation plans is authoritative
- Distributor counts, retention and any earnings data
- The Malaysian direct-selling license status, which is checkable at the national registry and was not verified here
- Whether the reported device injuries prompted any company action
Not advice
This is independent analysis for decision-making, not legal, financial or investment advice. Allegations reported by third parties should be verified against primary court and regulatory records before any decision.
Researched by Claude. Reviewed by an editor.
Every report is researched and written by Claude, Anthropic’s AI assistant, from the company’s own plan documents, policies, terms and regulatory file - then reviewed before publication by Rob Fore, who checks the sources and the stage-label on every allegation.
- Nine weighted dimensions, published with their weights
- The editor checks the evidence and cannot change the number - the build rejects any page whose grade does not reconcile to its own arithmetic
- Every affiliate position we hold is disclosed on the report it touches
- No company has paid for a grade, and no report carries an affiliate link
Looking at something else?
Enter any company name or website. If a report exists it opens instantly; if not, we start one.
OlyLife - frequently asked
QDoes the OlyLife terahertz device actually work as advertised?
QIs OlyLife FDA approved?
QHas OlyLife been banned anywhere?
QHow much does OlyLife cost to join?
QIs OlyLife a scam?
Author, editor and publisher
This report was researched and written by Claude, Anthropic’s AI assistant, working from primary documents - OlyLife’s own compensation plan, its policies and procedures, its terms of service, its income disclosure statement where one exists, and its regulatory and self-regulatory file. It was scored against nine weighted dimensions that are published in full, with their weights, on the methodology page.
Before publication it was reviewed by Rob Fore, who checks every source link, every figure against the document it came from, and every allegation against its stage-label - an investigation is not a finding, a warning letter is not an enforcement action, and a filed claim is not a verdict.
The editor does not set the grade. The published score is the weighted composite of the nine dimension scores, and the build refuses to emit a page where the two disagree by more than 0.06. A grade moves when the evidence moves it and not otherwise.
Rob Fore has marketed online since 1996, wrote Online MLM Marketing (2014), and is CEO of Listech Inc, the Nevada corporation that publishes this site. He holds affiliate positions in companies graded here - including LiveGood, which this site grades D, SendOutCards, which it grades C−, and the Home Business Academy, which it grades B−. Those positions are disclosed on the reports they touch, and changed nothing on this page.
About the author and our conflicts · Contact the editor · Corrections: corrections@opportunitygrade.com
Tell me if this grade changes
OlyLife is graded D- as of July 27, 2026. Grades move when the evidence moves - a new income disclosure, a regulatory action, a rewritten compensation plan. Leave your address and you will get one email if this one does.
One email when the grade moves, and nothing else. We will never use your address to promote an income opportunity of any kind, we do not sell, rent or share the list, and it is stored on our own infrastructure rather than with any company graded here. Unsubscribe removes everything.
Corrections
Every factual claim on this page is sourced, and the ones we could not stand up are named in the unable to verify list above. If something here is wrong, we want to know, and we would rather hear it from OlyLife than from a reader.
Write to corrections@opportunitygrade.com. Point at the specific sentence and send the document that contradicts it - a plan document, a filing, an income disclosure, a policy page. We will check it against the primary source, correct the page if it is wrong, and keep a dated record of the change. A grade moves if the evidence moves it.
This address reaches a person, not a form. We do not require a takedown demand, an NDA or a lawyer to accept a correction, and we do not remove a report because a company disputes its conclusion - only because the underlying facts turn out to be wrong.